Skip to main content
SpringerLink
Log in

Urgent Need for Early Diagnosis of Primary Liver Cancer

Glypican-3 is a Promising Candidate Biomarker

  • Emerging Technologies
  • Published:
Pharmaceutical & Diagnostic Innovation

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Filmus J, Capurro M. Glypican-3 and alpha-fetoprotein as diagnostic tests for hepatocellular carcinoma. Molecular Diagnosis 2005, 8(4) [in press]

  2. BioMosaics. BioMosaics licenses novel diagnostic test for primary liver cancer from Toronto hospital. Media release: 25 Nov 2003

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

Urgent Need for Early Diagnosis of Primary Liver Cancer. Pharmaceutical & Diagnostic Innovation 3, 7–8 (2005). https://doi.org/10.1007/BF03262544

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03262544

Keywords

Search

Navigation